Healthcare
Live Price
Offline$402.95
-0.94% today
1Y Change
-19.96%
Window
Jun 23, 2025 → Jun 1, 2026
Coverage: 236 bars · Jun 23, 2025 → Jun 1, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Intuitive Surgical, Inc. (ISRG) is a Healthcare stock with a market cap of $162.51B and listed on NASDAQ. The stock last traded around $402.95 and down 20.0% across the available one-year price window (Jun 23, 2025 → Jun 1, 2026). Baseline metrics include revenue growth of +20.5%, EPS growth of +22.3%, a dividend yield of 0.0%. What stands out right now is revenue +20.5%, EPS +22.3%, free cash flow +91.0% with operating margin 30.5% and ROIC 16.5%. Valuation already assumes a fairly strong business story at P/E 54.7 and price/sales 15.4. Overall, the current profile looks closer to a quality compounder than a generic broad-market placeholder. Stock Foundry combines ISRG price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
ISRG
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
ISRG Max Drawdown
-30.46%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for ISRG and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$5.7B
-8.2% YoY
FY Net Income
$1.7B
+28.9% YoY
Free Cash Flow
$1.7B
+81.1% YoY
Revenue Growth
+20.5%
EPS Growth
+22.3%
Gross Margin
66.3%
Net Margin
28.2%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 10.1B | 8.4B | 7.1B | 6.2B | 5.7B |
| Gross Profit | 6.6B | 5.6B | 4.7B | 4.2B | 4.0B |
| Operating Income | 2.9B | 2.3B | 1.8B | 1.6B | 1.8B |
| EBITDA | 3.6B | 2.8B | 2.2B | 1.9B | 2.1B |
| Net Income | 2.9B | 2.3B | 1.8B | 1.3B | 1.7B |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 3.4B | 2.0B | 2.8B | 1.6B | 1.3B |
| Total Assets | 20.6B | 18.8B | 15.4B | 13.0B | 13.6B |
| Total Liabilities | 2.7B | 2.3B | 2.0B | 1.9B | 1.6B |
| Shareholder Equity | 17.8B | 16.4B | 13.3B | 11.0B | 12.0B |
| Total Debt | 303M | 146M | 0 | 0 | 87M |
| Net Debt | -3.1B | -1.9B | -2.8B | -1.6B | -1.2B |
Cash flow positioning
Latest Full Year
Operating Cash Flow
2.1B
+40.2% YoY
Capital Expenditures
354M
+33.6% YoY
Free Cash Flow
1.7B
+81.1% YoY
Key ratios
Gross Margin
66.3%
Operating Margin
30.5%
Net Margin
28.2%
ROE
17.0%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.